Topiramate add-on for drug-resistant partial epilepsy.

Author: HuttonJ L, JetteN J, MarsonA G

Paper Details 
Original Abstract of the Article :
The majority of people with epilepsy have a good prognosis and their seizures are controlled by a single antiepileptic drug. However, up to 30 per cent develop drug-resistant epilepsy, especially those with partial onset seizures. In this review we summarize the current evidence regarding a new anti...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1002/14651858.CD001417

データ提供:米国国立医学図書館(NLM)

Topiramate: A Promising Add-on Treatment for Drug-Resistant Epilepsy

Epilepsy, a neurological disorder characterized by recurrent seizures, can be a challenging condition to manage. This review focuses on topiramate, an antiepileptic drug, and its effectiveness as an add-on treatment for drug-resistant partial epilepsy. The review summarizes current evidence, highlighting the potential benefits of topiramate in controlling seizures in patients who have not responded adequately to other medications.

Topiramate: A New Oasis in the Desert of Epilepsy Treatment

The review suggests that topiramate can be a valuable tool in the treatment of drug-resistant partial epilepsy, offering a potential new avenue for improving seizure control and reducing seizure frequency. This discovery is a significant step forward in the ongoing quest for effective treatments for this challenging neurological condition.

Finding Relief: Navigating the Desert of Epilepsy

Living with epilepsy can be a daunting journey, filled with uncertainty and the constant threat of seizures. This review provides a glimmer of hope, highlighting the potential of topiramate to provide relief from seizures and improve quality of life for those affected by this condition.

Dr. Camel's Conclusion

This review provides valuable insights into the potential benefits of topiramate as an add-on treatment for drug-resistant partial epilepsy. The findings suggest that topiramate can be a valuable tool in controlling seizures, offering a potential new avenue for improving patient outcomes. This research underscores the importance of ongoing research and development of new and effective treatments for epilepsy, aiming to alleviate the burden of this neurological condition.

Date :
  1. Date Completed 2002-09-24
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

12137625

DOI: Digital Object Identifier

10.1002/14651858.CD001417

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.